Staples and Office Depot, which have agreed to merge, are in talks with wholesaler Essendant Inc (ESND.O) to transfer about $600 million of corporate contracts to satisfy U.S antitrust concerns, the Wall street Journal said.
The terms of the divestiture proposal could change during talks with Federal Trade Commission officials, the Journal said, citing people familiar with the matter.
It isn’t clear whether the concessions will satisfy the FTC, the newspaper said.
Staples’ $6.3 billion offer for Office Depot has come under FTC’s scrutiny as it involves the top two companies in the industry.
The FTC will decide on the deal by Dec. 8, Office Depot had said in its earnings statement earlier this month.
In September, EU antitrust regulators also opened an extensive investigation into the deal, fearing possible price hikes.
Office Depot has said the closing of the deal could be delayed until early 2016.
Full content: Variety
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Top Antitrust Expert Joins Cravath from Paul Weiss
Jan 21, 2025 by
CPI
CMA Chief Removed as UK Government Targets Regulatory Overhaul
Jan 21, 2025 by
CPI
Court Denies Dismissal in Crab Price-Fixing Lawsuit
Jan 21, 2025 by
CPI
TikTok Stays Online for Now: Trump Floats US Ownership Deal
Jan 21, 2025 by
CPI
Hong Kong Watchdog Unveils Compliance Tool for Small Businesses
Jan 21, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Pharmacy Benefit Managers
Jan 20, 2025 by
CPI
Untangling the PBM Mess
Jan 20, 2025 by
Kent Bernard
Using Data, Not Anecdotes, to Analyze Criticisms of Pharmacy Benefit Managers
Jan 20, 2025 by
Dennis Carlton
Vertical Integration and PBMs: What, Me Worry?
Jan 20, 2025 by
Lawton Robert Burns & Bradley Fluegel
The Economics of Benefit Management in Prescription-Drug Markets
Jan 20, 2025 by
Casey B. Mulligan